- Report
- January 2026
- 160 Pages
Global
From €2919EUR$3,160USD£2,441GBP
€3648EUR$3,950USD£3,052GBP
- Report
- May 2026
- 250 Pages
Global
From €4147EUR$4,490USD£3,469GBP
- Report
- September 2026
- 198 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- September 2026
- 190 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- September 2026
- 182 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- April 2026
- 200 Pages
Global
From €2762EUR$2,990USD£2,310GBP
- Report
- December 2025
- 120 Pages
Global
From €5496EUR$5,950USD£4,597GBP
- Report
- May 2026
- 149 Pages
Global
From €3694EUR$3,999USD£3,089GBP
- Report
- May 2026
- 250 Pages
Global
From €4147EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4147EUR$4,490USD£3,469GBP
- Report
- September 2026
- 182 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- September 2026
- 180 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- September 2026
- 181 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- November 2026
- 173 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2026
- 317 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2026
- 636 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2026
- 206 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- June 2026
- 180 Pages
Global
From €4387EUR$4,750USD£3,670GBP
- Report
- January 2026
- 160 Pages
Global
From €2919EUR$3,160USD£2,441GBP
€3648EUR$3,950USD£3,052GBP
- Report
- April 2026
- 200 Pages
United States
From €2762EUR$2,990USD£2,310GBP

The Human Leukocyte Antigen (HLA) Test is a type of In Vitro Diagnostics (IVD) used to identify the presence of certain antigens in a patient's blood. It is used to diagnose a variety of conditions, including autoimmune diseases, organ transplantation, and blood transfusions. The test is also used to determine the compatibility of donor organs for transplantation. The HLA Test market is a rapidly growing segment of the IVD market, driven by the increasing prevalence of autoimmune diseases and the need for organ transplants. The market is expected to benefit from the development of new technologies and the introduction of new products.
Some of the major companies in the HLA Test market include Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN, Illumina, and Agilent Technologies. Show Less Read more